Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

ARCT

Arcturus Therapeutics Holdings Inc

Jun 21 • 04:00PM ET

27.45

Dollar change +0.86
Percentage change 3.23	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: ARKG XBI VTI IWM VXF IWN IBB VTWO VHT SCHA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.91	Insider Own	8.46%	Shs Outstand	26.83M	Perf Week	-13.13%
Market Cap	739.23M	Forward P/E	-	EPS next Y	-1.13	Insider Trans	-4.29%	Shs Float	24.63M	Perf Month	-8.04%
Income	-104.16M	PEG	-	EPS next Q	-1.50	Inst Own	97.30%	Short Float	16.70%	Perf Quarter	-17.14%
Sales	113.75M	P/S	6.50	EPS this Y	-206.40%	Inst Trans	-0.13%	Short Ratio	6.96	Perf Half Y	-15.30%
Book/sh	9.81	P/B	2.80	EPS next Y	63.07%	ROA	-23.41%	Short Interest	4.11M	Perf Year	9.76%
Cash/sh	12.75	P/C	2.15	EPS next 5Y	-	ROE	-35.12%	52W Range	17.52 - 45.00	Perf YTD	-12.94%
Dividend Est.	-	P/FCF	70.40	EPS past 5Y	12.40%	ROI	-35.72%	52W High	-39.00%	Beta	2.65
Dividend TTM	-	Quick Ratio	3.26	Sales past 5Y	310.16%	Gross Margin	-	52W Low	56.68%	ATR (14)	2.67
Dividend Ex-Date	-	Current Ratio	3.26	EPS Y/Y TTM	-193.29%	Oper. Margin	-51.90%	RSI (14)	40.06	Volatility	7.18% 8.98%
Employees	180	Debt/Eq	0.12	Sales Y/Y TTM	-59.44%	Profit Margin	-91.57%	Recom	1.00	Target Price	74.75
Option/Short	Yes / Yes	LT Debt/Eq	0.10	EPS Q/Q	-153.37%	Payout	-	Rel Volume	2.46	Prev Close	26.59
Sales Surprise	115.15%	EPS Surprise	18.94%	Sales Q/Q	-59.11%	Earnings	May 08 AMC	Avg Volume	590.61K	Price	27.45
SMA20	-19.96%	SMA50	-10.47%	SMA200	-7.83%	Trades		Volume	1,409,458	Change	3.23%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-13-23	Initiated	Canaccord Genuity	Buy	$90
Jul-24-23	Initiated	William Blair	Outperform	$71
May-11-23	Upgrade	H.C. Wainwright	Neutral → Buy	$19 → $51
Nov-14-22	Resumed	Wells Fargo	Overweight	$35
Nov-10-22	Downgrade	Robert W. Baird	Neutral → Underperform	$18
Nov-03-22	Upgrade	Citigroup	Neutral → Buy	$22 → $35
Nov-02-22	Upgrade	Barclays	Underweight → Equal Weight	$16 → $25
Aug-10-22	Downgrade	Raymond James	Mkt Perform → Underperform
Jul-19-22	Resumed	Cantor Fitzgerald	Overweight	$86 → $39
May-11-22	Upgrade	Robert W. Baird	Underperform → Neutral	$21 → $18
Apr-21-22	Downgrade	Citigroup	Buy → Neutral	$86 → $29
Jan-31-22	Upgrade	Raymond James	Underperform → Mkt Perform
Aug-12-21	Downgrade	Raymond James	Mkt Perform → Underperform
Aug-11-21	Downgrade	Goldman	Neutral → Sell	$29
Aug-10-21	Downgrade	Robert W. Baird	Neutral → Underperform	$31
Jul-02-21	Initiated	Cantor Fitzgerald	Overweight	$71
Jun-25-21	Resumed	Goldman	Neutral	$29
Jun-21-21	Downgrade	Barclays	Equal Weight → Underweight	$33 → $25
Jun-04-21	Resumed	Robert W. Baird	Neutral	$31
Feb-17-21	Downgrade	B. Riley Securities	Neutral → Sell

Show Previous Ratings

Jun-20-24 08:00AM	Arcturus Therapeutics Appoints Moncef Slaoui, Ph.D., to Board of Directors (Business Wire)
Jun-15-24 02:49AM	Insider Sale: CFO Andy Sassine Sells 50,000 Shares of Arcturus Therapeutics Holdings Inc (ARCT) (GuruFocus.com)
Jun-07-24 10:30AM	Arcturus Therapeutics Presents New Clinical Data at 47th Annual European Cystic Fibrosis Conference (Business Wire) -25.31%
Jun-04-24 07:00PM	Insider Sale: Chief Scientific Officer & COO Pad Chivukula Sells 26,000 Shares of Arcturus ... (GuruFocus.com) +7.17%
May-28-24 06:30AM	Arcturus Therapeutics Announces Positive Development for Cystic Fibrosis Program (Business Wire) +26.31%
07:00AM	Loading…
May-22-24 07:00AM	Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines (GlobeNewswire) +8.48%
May-20-24 08:30AM	Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics' COVID-19 Vaccine (PR Newswire)
May-15-24 04:01PM	Arcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences (Business Wire) +5.12%
May-09-24 11:13AM	Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:48AM	Arcturus Therapeutics Holdings Inc (ARCT) (Q1 2024) Earnings Call Transcript Highlights: ... (GuruFocus.com)
May-08-24 09:58PM	ARCT Stock Earnings: Arcturus Therapeutics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:43PM	Arcturus Therapeutics: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	Arcturus Therapeutics Announces First Quarter 2024 Financial Update and Pipeline Progress (Business Wire)
May-01-24 10:01AM	Analysts Estimate Arcturus Therapeutics (ARCT) to Report a Decline in Earnings: What to Look Out for (Zacks) +9.15%
Apr-25-24 04:01PM	Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 8, 2024 (Business Wire)
01:34AM	Loading…
Mar-28-24 01:34AM	Arcturus Therapeutics Holdings Inc (ARCT) Insider Sells Shares (GuruFocus.com)
Mar-22-24 01:26AM	Arcturus Therapeutics Holdings Inc's Chief Scientific Officer & COO Pad Chivukula Sells ... (GuruFocus.com)
Mar-09-24 01:09PM	12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds (Insider Monkey)
Mar-08-24 12:10PM	Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2023 Earnings Call Transcript (Insider Monkey)
06:54AM	Q4 2023 Arcturus Therapeutics Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-07-24 10:42PM	Arcturus Therapeutics Reports Fiscal Year 2023 Financial Results and Pipeline Developments (GuruFocus.com)
05:10PM	Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:21PM	Arcturus Therapeutics: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progress (Business Wire)
Mar-04-24 01:23PM	Arcturus (ARCT) Stock Surges 73% in 3 Months: Here's Why (Zacks) -5.24%
Feb-26-24 03:20PM	7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff (InvestorPlace) +9.41%
09:00AM	Arcturus Therapeutics to Present at the Barclays 26th Annual Global Healthcare Conference (Business Wire)
Feb-22-24 08:30AM	Arcturus Therapeutics Receives Orphan Medicinal Product Designation from the European Commission (EC), for ARCT-032, for the Treatment of Cystic Fibrosis (Business Wire) +6.12%
Feb-21-24 01:04PM	Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for February 2024 (InvestorPlace)
Feb-20-24 04:39PM	3 Tech Stocks That Could Be Multibaggers in the Making: February Edition (InvestorPlace)
09:00AM	Loading…
09:00AM	Arcturus Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 7, 2024 (Business Wire)
Feb-05-24 08:30AM	New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrate Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Booster (PR Newswire)
Jan-23-24 04:16AM	18 High Growth Low PE Stocks (Insider Monkey)
Jan-05-24 01:17PM	PassPort Technologies Commences Collaborative Research with Arcturus Therapeutics to Evaluate Transdermal mRNA delivery systems (PR Newswire)
Dec-21-23 08:00AM	CSL and Arcturus Therapeutics ARCT-154 Demonstrates Non-Inferiority to Original Strain and Superior Immunogenicity to Omicron BA.4/5 Variant Compared to First-Generation mRNA Vaccine Booster (Business Wire)
Dec-17-23 12:03PM	7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar (InvestorPlace)
Dec-13-23 10:39PM	3 Biotech Stocks With Promising Pipelines and Big Growth Potential in 2024 (InvestorPlace) +11.18% +8.05%
Dec-08-23 10:13AM	12 Best Healthcare Stocks For the Long-Term (Insider Monkey)
Dec-04-23 08:30AM	Arcturus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Nov-28-23 08:05AM	Japan's Ministry of Health, Labour and Welfare Approves CSL and Arcturus Therapeutics' ARCT-154, the first Self-Amplifying mRNA vaccine approved for COVID in adults (PR Newswire)
07:56AM	Arcturus' (ARCT) CF Drug Gets FDA's Orphan Status, Stock Up (Zacks)
Nov-27-23 08:30AM	Arcturus Therapeutics Receives Orphan Drug Designation from the U.S. FDA for ARCT-032, for the Treatment of Cystic Fibrosis (Business Wire) +7.90%
Nov-15-23 01:26PM	Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q3 2023 Earnings Call Transcript (Insider Monkey) +16.08%
11:30AM	Q3 2023 Arcturus Therapeutics Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-14-23 05:19PM	Arcturus Therapeutics Holdings Inc (ARCT) Reports Significant Revenue Growth in Q3 2023 (GuruFocus.com) +9.54%
04:13PM	Arcturus Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Arcturus Therapeutics Announces Third Quarter 2023 Financial Update and Pipeline Progress (Business Wire)
10:56AM	The 3 Most Undervalued Biotech Stocks to Buy: November 2023 (InvestorPlace)
Oct-25-23 04:01PM	Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 14, 2023 (Business Wire)
Oct-23-23 04:01PM	Arcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences (Business Wire)
Oct-04-23 11:01PM	Insider Sell: Pad Chivukula Sells 5,000 Shares of Arcturus Therapeutics Holdings Inc (GuruFocus.com)
08:30AM	Arcturus Therapeutics Joint Venture mRNA Manufacturing Partner, ARCALIS, Awarded Additional Financial Grants from Japanese Government (Business Wire)
Sep-26-23 08:30AM	Arcturus Therapeutics and Cystic Fibrosis Foundation Extend Agreement to Advance ARCT-032, an Investigational Messenger RNA (mRNA) Therapeutic to Treat Cystic Fibrosis (Business Wire)
Sep-19-23 08:30AM	Study Shows Novel sa-mRNA Vaccines Offer Robust, Broad, Enduring Protection Against COVID-19 Variants (Business Wire)
Sep-05-23 08:30AM	Arcturus Therapeutics and CSL Announce European Medicines Agency Validates Marketing Authorization Application for ARCT-154 Vaccine to Prevent COVID-19 (Business Wire)
Aug-17-23 08:30AM	Arcturus Therapeutics to Attend Upcoming Investor Conferences (Business Wire)
Aug-14-23 09:00AM	Arcturus Therapeutics Joint Venture mRNA Manufacturing Partner, ARCALIS, Awarded $115 Million in Grants from the Japanese Government (Business Wire) +6.37%
Aug-10-23 07:15AM	New Strong Sell Stocks for August 10th (Zacks)
Aug-08-23 02:39PM	Why Shares of Arcturus Therapeutics Dropped on Tuesday (Motley Fool) -19.22%
01:09PM	Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q2 2023 Earnings Call Transcript (Insider Monkey)
08:43AM	Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Analysts Just Cut Their EPS Forecasts Substantially (Simply Wall St.)
07:39AM	Q2 2023 Arcturus Therapeutics Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-23 07:50PM	Arcturus Therapeutics (ARCT) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
06:43PM	Arcturus Therapeutics: Q2 Earnings Snapshot (AP Finance)
04:01PM	Arcturus Therapeutics Announces Second Quarter 2023 Financial Update and Pipeline Progress (Business Wire)
Aug-04-23 09:21AM	4 Biotech Stocks Set to Outpace Q2 Earnings Estimates (Zacks)
Jul-28-23 05:14PM	3 Biotech Stocks to Buy Before the Breakout (InvestorPlace)
Jul-24-23 04:01PM	Arcturus Therapeutics to Report Second Quarter 2023 Financial Results and Provide Corporate Update on August 7, 2023 (Business Wire) +5.38%
Jul-18-23 06:22AM	3 Biotech Stocks for Getting Rich in 2023 (InvestorPlace)
Jul-16-23 08:18PM	Arcturus Therapeutics (ARCT) Surges 15.0%: Is This an Indication of Further Gains? (Zacks)
Jul-14-23 02:36PM	Biotech, Cboe Rally To New Highs, Top Buy Points (Investor's Business Daily) +15.03%
Jul-05-23 06:15AM	Calculating The Intrinsic Value Of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) (Simply Wall St.)
Jun-14-23 08:24AM	Arcturus Therapeutics Holdings (NASDAQ:ARCT) shareholder returns have been stellar, earning 225% in 5 years (Simply Wall St.)
Jun-01-23 08:30AM	Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for ARCT-810, mRNA Therapeutic Candidate for Ornithine Transcarbamylase Deficiency (Business Wire)
May-18-23 07:16AM	Growth Investors: Industry Analysts Just Upgraded Their Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Revenue Forecasts By 76% (Simply Wall St.)
May-12-23 02:04AM	4 big analyst picks: Albemarle scores fresh Overweight rating (Investing.com) -5.50%
May-09-23 05:35PM	Arcturus Therapeutics (ARCT) Q1 Earnings and Revenues Miss Estimates (Zacks)
04:37PM	Arcturus Therapeutics: Q1 Earnings Snapshot (AP Finance)
04:01PM	Arcturus Therapeutics Announces First Quarter 2023 Financial Update and Pipeline Progress (Business Wire)
09:29AM	12 Best Fast Growth Stocks to Buy Now (Insider Monkey)
May-08-23 07:43AM	Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock? (Simply Wall St.) +5.24%
Apr-28-23 01:39PM	12 Best Fast Growth Stocks to Buy Now (Insider Monkey)
Apr-26-23 08:30AM	Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 9, 2023 (Business Wire) -5.09%
Apr-17-23 07:10AM	Why Investors Shouldn't Be Surprised By Arcturus Therapeutics Holdings Inc.'s (NASDAQ:ARCT) 79% Share Price Surge (Simply Wall St.)
Mar-30-23 08:29AM	Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-29-23 11:45AM	Why Arcturus Therapeutics Stock Is Soaring Today (Motley Fool) +30.13%
Mar-28-23 05:15PM	Arcturus Therapeutics (ARCT) Beats Q4 Earnings and Revenue Estimates (Zacks)
04:01PM	Arcturus Therapeutics Announces Fourth Quarter 2022 Financial Update and Pipeline Progress (Business Wire)
Mar-27-23 09:11AM	Market Sentiment Around Loss-Making Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) (Simply Wall St.)
Mar-23-23 06:18AM	Immuneering Corporation (IMRX) Soars 16.9%: Is Further Upside Left in the Stock? (Zacks)
Mar-07-23 08:00AM	Arcturus Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on March 28, 2023 (Business Wire)
Feb-06-23 08:30AM	Arcturus Therapeutics to Attend Upcoming Investor Conferences (Business Wire)
Jan-31-23 08:30AM	Arcturus Therapeutics Announces Clinical Trial Application for ARCT-032 Received Approval to Proceed into First-in-Human Studies to Treat Cystic Fibrosis (Business Wire)
Dec-28-22 11:35AM	Swelling losses haven't held back gains for Arcturus Therapeutics Holdings (NASDAQ:ARCT) shareholders since they're up 109% over 5 years (Simply Wall St.)
Dec-19-22 08:30AM	Arcturus Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference (Business Wire) -7.04%
Dec-13-22 08:30AM	Arcturus Appoints John Markels, Ph.D. to its Board of Directors (Business Wire) +7.29%
Dec-12-22 08:30AM	CSL Announces Closing of Global Collaboration and Licensing Agreement with Arcturus Therapeutics (PR Newswire)
Dec-01-22 10:23AM	The Founder of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), Joseph Payne, Just Bought A Few More Shares (Simply Wall St.)
Nov-16-22 05:24AM	These Analysts Just Made A Significant Downgrade To Their Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) EPS Forecasts (Simply Wall St.)
Nov-12-22 07:04AM	Arcturus Therapeutics Holdings Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.)

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Markels John	Director	Jun 14 '24	Option Exercise	0.00	3,131	0	3,131	Jun 18 09:00 PM
HOLMES EDWARD W	Director	Jun 14 '24	Option Exercise	0.00	3,131	0	3,131	Jun 18 09:01 PM
Marantz Jing L.	Director	Jun 14 '24	Option Exercise	0.00	3,131	0	3,131	Jun 18 09:01 PM
FARRELL PETER C	Director	Jun 14 '24	Option Exercise	0.00	3,131	0	55,741	Jun 18 09:00 PM
BARLOW JAMES F	Director	Jun 14 '24	Option Exercise	0.00	3,131	0	13,131	Jun 18 09:00 PM
Marquet Magda	Director	Jun 14 '24	Option Exercise	0.00	3,131	0	3,131	Jun 18 09:00 PM
SASSINE ANDY	Chief Financial Officer	Jun 12 '24	Sale	32.03	50,000	1,601,500	220,526	Jun 14 04:06 PM
Chivukula Pad	Chief Scientific Officer & COO	Jun 05 '24	Sale	45.00	114	5,130	447,334	Jun 07 05:01 PM
Chivukula Pad	Chief Scientific Officer & COO	Jun 03 '24	Sale	40.01	26,000	1,040,234	447,448	Jun 04 04:05 PM
Chivukula Pad	Chief Scientific Officer & COO	Mar 25 '24	Sale	35.02	17,435	610,574	473,448	Mar 27 04:15 PM
Chivukula Pad	Chief Scientific Officer & COO	Mar 19 '24	Sale	35.01	8,565	299,839	490,883	Mar 21 05:27 PM
Chivukula Pad	Chief Scientific Officer & COO	Nov 01 '23	Sale	18.72	5,000	93,602	499,448	Nov 03 04:30 PM
Chivukula Pad	Chief Scientific Officer & COO	Oct 02 '23	Sale	25.61	5,000	128,062	504,448	Oct 04 04:06 PM
Chivukula Pad	Chief Scientific Officer & COO	Sep 01 '23	Sale	31.45	5,000	157,264	509,448	Sep 05 04:05 PM
Chivukula Pad	Chief Scientific Officer & COO	Aug 01 '23	Sale	34.91	5,000	174,550	514,448	Aug 03 04:15 PM
Kummerfeld Keith C	See Remarks	Jul 14 '23	Option Exercise	8.96	6,968	62,408	7,918	Jul 18 06:50 PM
Chivukula Pad	Chief Scientific Officer & COO	Jul 14 '23	Sale	35.01	25,000	875,250	519,448	Jul 18 06:50 PM
Kummerfeld Keith C	See Remarks	Jul 14 '23	Sale	35.00	6,968	243,880	950	Jul 18 06:50 PM
Chivukula Pad	Chief Scientific Officer & COO	Jul 03 '23	Sale	28.75	5,000	143,750	544,448	Jul 07 06:01 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ARCT

Arcturus Therapeutics Holdings Inc

Upgrade your FINVIZ experience